PharmaBoardroom

Anil Okay – General Manager, Adalvo & Chief Commercial…

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach, and commercial strategy…

Jean-Paul Clozel – CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia's unique value proposition as a biotech focused on small molecules, how agnosticism in…

Jon Helsdingen – General Manager, AbbVie Switzerland

AbbVie Switzerland's Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of…

Khalid Saleh – Managing Director, Mera Pharma

Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand via CMOs, and its evolution from food…

Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…

In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…

Sissel Lønning Andresen – Country Manager & Internal…

Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years, what other Pfizer affiliates can…

Larry St Onge – President, Life Sciences and Healthcare,…

DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented cross-industry collaboration that…

The Pharmaceutical Strategy for Europe – A Game-Changer for the…

On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of ensuring that “patients have access…

Growth, COVID-19 Response & Essential Medicines Industry…

Graeme Duncan, CEO of ADVANZ PHARMA, highlights how the specialty generics firm has revitalized its operations since 2018 both culturally and…

Christian Probst – General Manager, GSK Norway

Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of bringing clinical trials back to…

Kirsti Nyhus – Market Access & External Affairs…

AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the importance of bringing clinical trials…

Eisai Targeting Global Leadership in Neurology & Oncology…

Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma player, with pharmaceutical revenues of…

Tagged with strategy